Research Article

The Sirtuin 3 Expression Profile Is Associated with Pathological and Clinical Outcomes in Colon Cancer Patients

Figure 1

SIRT3 immunohistochemical staining in colon carcinoma tissues. SIRT3 immunohistochemical staining in colon carcinoma tissue sample from colon cancer patients. SIRT3 was mainly expressed in the cytoplasm of cancer tissues. SIRT3 is mildly expressed in the noncancerous tissue (Figure 1(a)). In colon cancer samples, the SIRT3 expression was stronger than noncancerous tissues. Figure 1(b) shows the low expression and Figure 1(c) shows high SIRT3 expression in samples from different patient. The CD31 immunohistochemical staining in colon carcinoma tissue sample from colon cancer patients. Compared to the noncancerous tissue (Figure 1(d)), the colon cancer samples had higher CD31 expression levels. Figure 1(e) shows the low CD31 expression and Figure 1(f) shows high CD31 expression.
871263.fig.001a
(a)
871263.fig.001b
(b)
871263.fig.001c
(c)
871263.fig.001d
(d)
871263.fig.001e
(e)
871263.fig.001f
(f)